Ionic electroactive polymers have been developed as mechanical sensors or actuators, taking advantage of the electromechanical coupling of the materials. This research attempts to take advantage of the chemomechanical and chemoelectrical coupling by characterizing the transient response as the polymer undergoes an ion exchange, thus using the polymer for ionic sensing. Nafion™ is a biocompatible material, and an implantable polymeric ion sensor which has applications in the biomedical field for bone healing research. An ion sensor and a strain gauge could determine the effects of motion allowed at the fracture site, thus improving rehabilitation procedures for bone fractures. The charge sensitivity of the material and the capacitance of the material were analyzed to determine the transient response. Both measures indicate a change when immersed in ionic salt solutions. It is demonstrated that measuring the capacitance is the best indicator of an ion exchange. Relative to a flat response in deionized water (±2%), the capacitance of the polymer exhibits an exponential decay of ~25% of its peak when placed in a salt solution. A linear correlation between the time constant of the decay and the ionic size of the exchanging ion was developed that could reasonably predict a diffusing ion. Tests using an energy dispersive spectrometer (EDS) indicate that 90% of the exchange occurs in the first 20 minutes, shown by both capacitance decay and an atomic level scan. The diffusion rate time constant was found to within 0.3% of the capacitance time constant, confirming the ability of capacitance to measure ion exchange. / Master of Science

Orientador: Paulo Roberto Bueno / Coorientador: Flávio Cesar Bedatty Fernandes / Banca: Hideko Yamanaka / Banca: Marina Ribeiro Batistuti / Resumo: Desde a primeira descrição de biossensor reportada por Clark e Lyons em 1962, houve um extenso trabalho no desenvolvimento e aprimoramento de novas técnicas de biossensoriamento para detecção de biomarcadores com relevância médica. Destaca-se nesse processo o estudo de superfície de eletrodos, pois esse influencia diretamente em aspectos como; sensibilidade, estabilidade e qualidade do sinal. Portanto, este projeto consiste em avaliar comparativamente três superfícies de eletrodos baseadas em nanoestruturas contendo nanopartículas de azul da Prússia, funcionando com sonda redox do sistema, e materiais carbonáceos (como óxido de grafeno e nanotubos de carbono) para aplicação em biossensores. Foram avaliados aspectos como composição, características capacitivas redox e estabilidade de sinal. A técnica de análise utilizada é a espectroscopia de capacitância eletroquímica (ECE) que apresenta vantagens como não usar amplificadores de sinal (sondas redox) em solução, configuração esta, importante para métodos de diagnóstico point-of-care. Das superfícies analisadas, a composta por nanopartículas de azul da Prússia e óxido de grafeno (PBNP+GO) apresentou os melhores parâmetros de estabilidade e compatibilidade com os aspectos teóricos da técnica de ECE, sendo então selecionada para realização de testes de biossensoriamento que, através da funcionalização da superfície com anticorpos Anti-IL-6, detectaram seletivamente a presença do biomarcador IL-6. / Abstract: Since the first description of biosensor reported by Clark and Lyons in 1962, numerous works related to the development and enhancement of novel medical biosensing techniques have been published. In that context, it must be highlighted the study of electrode surfaces as it has direct influence in aspects like; sensitivity, stability and signal quality. Therefore, this project aims to evaluate three electrode surfaces based on nanostructures with Prussian blue nanoparticles, as redox probe, and carbonaceous materials (like graphene oxide and carbon nanotubes) and their application in biosensors. It was evaluated aspects like composition, redox capacitive characteristics and signal stability. The electrochemical capacitance spectroscopy technique (ECE) was used as it offers several advantages like no need of signal amplifiers (redox probes) in solution and, then, making this technique more adequate for point-of-care diagnosis. Among the analysed surfaces, the one composed by Prussian blue nanoparticles and graphene oxide (PBNP+GO) was identified as the best surface in terms of stability and compatibility to the theoretical aspects of ECE. Therefore, that structure was selected to further biosensing essays, by functionalizing the surface with Anti-IL-6 antibodies, that indicated the selective detection of the IL-6 biomarker. / Mestre

Le facteur de motilité autocrine (AMF) est une cytokine sécrétée par les cellules tumorales qui a été détectée dans le sérum et l'urine de patients cancéreux. Cette enzyme stimule la motilité des cellules cancéreuses in vitro et provoque des métastases in vivo. Elle peut être utilisée comme un biomarqueur métastasique.Dans cette étude, un biocapteur électrochimique sensible et spécifique a été conçu pour la détection et la quantification d'une enzyme modèle de l’AMF humain : la PGI de mammifère. Le biocapteur a été construit par liaison de 6-phosphate-D-fructose (F6P) sur une surface d'or d’électrode fonctionnalisée covalemment par des groupements oxyamine.La reconnaissance entre l’enzyme et le biorécepteur a été quantifiée par spectroscopie d'impédance électrochimique et voltammétrie dans une gamme de 10 fM à 100 nM. La limite de détection mesurée est de 6,6 fM. La sélectivité a été prouvée, ainsi que la reproductibilité. Notre biocapteur est une preuve de concept très prometteuse d'un futur dispositif analytique miniaturisé conçu pour la détection rapide, facile et précis de l'AMF. Il pourrait en outre contribuer à valider l'AMF en tant que nouveau biomarqueur du cancer métastatique.Afin d’étudier les interactions mises en jeu dans la reconnaissance entre l’enzyme et le biorécepteur, des études de mécanique moléculaire polarisable via le champ de forces SIBFA ont été réalisées. SIBFA est un champ de forces de seconde génération basé sur les résultats des décompositions ab-initio de l’énergie d’interaction et inclut donc la polarisation mais aussi l’énergie de transfert de charge.Pour cette étude nous avons mis en place deux modèles d’AMF pour SIBFA, une forme entière et une forme réduite, et nous avons construit un mime du biocapteur pour SIBFA. Pour cela, il a fallu concevoir et calibrer chaque fragment nécessaire à l’élaboration du mime. Ensuite différentes minimisations d’énergie ont été réalisées, en prenant en compte ou non la solvatation, puis des études sur les interactions mises en jeu ont été effectuées. / Autocrine motility factor (AMF) is a cytokine secreted by tumor cells that could be detected in the serum and the urine of cancer patients. This enzyme stimulates tumor cells motility in vitro and causes metastasis in vivo. It can be used as a biomarker of metastasis.In this study, a sensitive and specific electrochemical biosensor was designed for the detection and quantitation of a model of the human enzyme AMF: the mammalian PGI. The biosensor was constructed by covalently binding D-fructose 6-phosphate (F6P) on the oxyamine functionalized surface of a gold electrode.Recognition between the enzyme and the bioreceptor was quantified by electrochemical impedance spectroscopy and voltammetry in the range of 10 fM to 100 nM. The measured detection limit was 6.6 fM. Selectivity and reproducibility were also proven. Our biosensor is a promising proof of concept for the design of a future miniaturized analytical device for fast, easy and accurate detection of AMF. It could also help validate the AMF as a new biomarker of metastatic cancer.To study the interactions involved in the recognition process between the enzyme and the bioreceptor, we performed polarizable molecular mechanic studies using the force field SIBFA. SIBFA is a second-generation force field based on the results of ab- initio decomposition energy of interaction and therefore includes not only the polarization but also the charge transfer energy.For this study we have developed two models of AMF for SIBFA, an entire form and a reduced form, and we built a mime of the biosensor for SIBFA. For this, it was necessary to design and calibrate each fragment essential for the development of the mime. Then, different energy minimizations were carried out, some of which taking into account solvation parameters. Studies of interactions between the mime and the AMF model are being carried out.

No description available.

Development of repellent surfaces which can supress bacteria adhesion, blood contamination and thrombosis, and non-specific adhesion on diagnostic devices has been a topic of intense research as these characteristics are in high demand. This thesis focused on design and development of omniphobic surfaces based on hierarchical structures and their application for preventing pathogenic contamination and biosensing. First, a flexible hierarchical heat-shrinkable wrap featuring micro and nanostructures, was developed with straightforward scalable methods which can be applied to existing surfaces. These surfaces reduced biofilm formation of World Health Organization-designated priority pathogens as well as minimized risk of spreading contamination from intermediate surfaces. This is due to the broad liquid repellency and the presence of reduced anchor points for bacterial adhesion on the hierarchical surfaces. Next, the developed surfaces were applied to minimize blood contamination and clot formation as well as facile integration of hydrophilic patterns. This led to droplet compartmentalization and was utilized for detection of Interleukin 6 in a rapid dip-based assay. Furthermore, in a review article the need for anti-viral or virus repellent surfaces and future perspectives were discussed as the global COVID-19 pandemic surged and attracted interest toward innovative technologies for suppressing the spread of pathogens. To address the pressing issue of non-specific adhesion in diagnostics devices, an omniphobic liquid infused electrochemical biosensor was developed. This was achieved by electroplating gold nanostructures on fluorosilanized gold electrodes. These electrodes demonstrated rapid and specific detection of Escherichia coli within an hour in complex biological liquids (blood, urine, etc.) without dilutions or amplification steps from clinical patient samples which are major bottle necks when rapid detection systems are sought for at the point of care. / Thesis / Doctor of Philosophy (PhD) / Repellent surfaces have a variety of applications in healthcare, for coating medical devices (e.g. indwelling implants, stethoscopes, and other external devices.), coating hospital surfaces for blood and pathogen repellency, and for developing anti-fouling diagnostic devices. Furthermore, they can be applied in the food sector for limiting contaminations, and in public areas on high-touch surfaces to eliminate the spread of infection. Therefore, there is a need for repellent surface which can be easily applied to surfaces with various form factors while having an easy fabrication method. Featuring hierarchical structures on a heat-shrinkable material, a repellent wrap was designed to be integrated on existing surfaces and repel pathogens and suppress the spread of infection as an intermediate surface. Similar concept was used for designing blood repellent surfaces which were patterned with hydrophilic regions for a rapid dip-based biosensing platform. Finally, surface textures on conductive materials with liquid infused repellent coatings were investigated for electrochemical biosensing in complex biological liquids.

Submitted by RAPHAEL MAZZINE BARBOSA DE OLIVEIRA (mazzine.r@gmail.com) on 2018-08-31T12:54:04Z No. of bitstreams: 1 DISSERTACAO_RMAZZINE.pdf: 2481284 bytes, checksum: e17b453dc770c4f6b899c9c0a5de342a (MD5) / Approved for entry into archive by Ana Carolina Gonçalves Bet null (abet@iq.unesp.br) on 2018-09-05T12:38:02Z (GMT) No. of bitstreams: 1 oliveira_rmb_me_araiq_int.pdf: 2195098 bytes, checksum: 013fbe713d5edbed6ff4d629e660b906 (MD5) / Made available in DSpace on 2018-09-05T12:38:02Z (GMT). No. of bitstreams: 1 oliveira_rmb_me_araiq_int.pdf: 2195098 bytes, checksum: 013fbe713d5edbed6ff4d629e660b906 (MD5) Previous issue date: 2018-08-21 / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) / Desde a primeira descrição de biossensor reportada por Clark e Lyons em 1962, houve um extenso trabalho no desenvolvimento e aprimoramento de novas técnicas de biossensoriamento para detecção de biomarcadores com relevância médica. Destaca-se nesse processo o estudo de superfície de eletrodos, pois esse influencia diretamente em aspectos como; sensibilidade, estabilidade e qualidade do sinal. Portanto, este projeto consiste em avaliar comparativamente três superfícies de eletrodos baseadas em nanoestruturas contendo nanopartículas de azul da Prússia, funcionando com sonda redox do sistema, e materiais carbonáceos (como óxido de grafeno e nanotubos de carbono) para aplicação em biossensores. Foram avaliados aspectos como composição, características capacitivas redox e estabilidade de sinal. A técnica de análise utilizada é a espectroscopia de capacitância eletroquímica (ECE) que apresenta vantagens como não usar amplificadores de sinal (sondas redox) em solução, configuração esta, importante para métodos de diagnóstico point-of-care. Das superfícies analisadas, a composta por nanopartículas de azul da Prússia e óxido de grafeno (PBNP+GO) apresentou os melhores parâmetros de estabilidade e compatibilidade com os aspectos teóricos da técnica de ECE, sendo então selecionada para realização de testes de biossensoriamento que, através da funcionalização da superfície com anticorpos Anti-IL-6, detectaram seletivamente a presença do biomarcador IL-6. / Since the first description of biosensor reported by Clark and Lyons in 1962, numerous works related to the development and enhancement of novel medical biosensing techniques have been published. In that context, it must be highlighted the study of electrode surfaces as it has direct influence in aspects like; sensitivity, stability and signal quality. Therefore, this project aims to evaluate three electrode surfaces based on nanostructures with Prussian blue nanoparticles, as redox probe, and carbonaceous materials (like graphene oxide and carbon nanotubes) and their application in biosensors. It was evaluated aspects like composition, redox capacitive characteristics and signal stability. The electrochemical capacitance spectroscopy technique (ECE) was used as it offers several advantages like no need of signal amplifiers (redox probes) in solution and, then, making this technique more adequate for point-of-care diagnosis. Among the analysed surfaces, the one composed by Prussian blue nanoparticles and graphene oxide (PBNP+GO) was identified as the best surface in terms of stability and compatibility to the theoretical aspects of ECE. Therefore, that structure was selected to further biosensing essays, by functionalizing the surface with Anti-IL-6 antibodies, that indicated the selective detection of the IL-6 biomarker. / 1583843

Submitted by Haroudo Xavier Filho (haroudo.xavierfo@ufpe.br) on 2016-04-01T16:41:18Z No. of bitstreams: 2 license_rdf: 1232 bytes, checksum: 66e71c371cc565284e70f40736c94386 (MD5) Priscila.pdf: 3187592 bytes, checksum: a982eac78d937dd89e264fd88f2d7be9 (MD5) / Made available in DSpace on 2016-04-01T16:41:18Z (GMT). No. of bitstreams: 2 license_rdf: 1232 bytes, checksum: 66e71c371cc565284e70f40736c94386 (MD5) Priscila.pdf: 3187592 bytes, checksum: a982eac78d937dd89e264fd88f2d7be9 (MD5) Previous issue date: 2015-02-26 / FACEPE / O câncer de próstata (CaP) é um dos tipos de tumor maligno mais incidente na população mundial, sendo também uma das principais causas de mortalidade por câncer. Geralmente ocorre em homens idosos e não é percebido em seus estágios iniciais. Para detectar o câncer de próstata, é de grande importância a avaliação pela dosagem sérica do antígeno específico da próstata (PSA), considerado o marcador tumoral da próstata. Porém, alterações nos níveis séricos do PSA são observadas também em doenças benignas da próstata, reduzindo a sensibilidade e especificidade do teste para se obter o diagnóstico. Uma peculiaridade do câncer que pode ser relevante no diagnóstico é a alteração no padrão de glicosilação de glicoproteínas secretadas e de superfície celular. A identificação de mudanças na expressão de glicanos permite a detecção precoce de vários tipos de câncer, inclusive o câncer de próstata. As lectinas são ferramentas empregadas para detectar tais alterações, graças à propriedade de reconhecer carboidratos com especificidade. Uma grande novidade no campo de estudos com lectinas é o desenvolvimento de pequenos dispositivos conhecidos como biossensores eletroquímicos baseados em lectinas para análise do perfil de glicoproteínas em processos fisiopatológicos. Esses dipositivos são elaborados utilizando eletrodos geralmente modificados com polímeros e nanomateriais, onde a lectina pode ser imobilizada e sua interação com o carboidrato quantificada com elevada sensibilidade e em tempo real. Neste trabalho foi realizado um estudo bioeletroquímico da lectina de Cratylia mollis (CramoLL) para caracterizar o padrão de glicosilação em soros de indivíduos saudáveis, com hiperplasia benigna da próstata (HBP) e CaP, utilizando biossensor eletroquímico baseado em CramoLL, imobilizada sobre eletrodo de carbono vítreo modificado com o polímero catiônico poli-Llisina (PLL) e nanotubos de carbono (NTC). Análises eletroquímicas e ópticas mostraram a formação de um filme de PLL e NTC na superfície eletródica, onde os NTC proporcionaram um aumento na área sensora de 71,2%, e nos valores de corrente anódica e catódica, e aumentaram a estabilidade da superfície, graça às propriedades físico-químicas dessas nanoestruturas. Foram investigadas as concentrações ótimas de PLL e NTC. CramoLL foi imobilizada com sucesso, numa concentração ótima de 200 μg mL-1. A interação entre CramoLL e metil-α-D-manopiranose (MeαMan)/ fetuína foi confirmada utilizando a técnica de voltametria de onda quadrada, mostrando que a lectina manteve sua atividade biológica após imobilização. Foram obtidas curvas de calibração para diferentes concentrações dos glicanos, com faixa linear de 0,96 e 38,4 μg mL-1 de MeαMan (r= 0,982, p < 0,001) e limite de detecção (LD) de 0,04 μg mL-1e de 0,5 a 25 μg mL-1 de fetuína (r= 0,994, p< 0,001) e LD = 0,05 μg mL-1. O biossensor baseado em CramoLL foi exposto à amostras de soro de indivíduos sadios (controle), com HBP e CaP com escores de Gleason 6, 7 e 9 para analisar a interação entre CramoLL e glicoproteínas dos soros de cada grupo. Os sinais de correntes obtidos por voltametria de onda quadrada mostraram diferenças significativas entre o grupo controle e os grupos HBP, CaP escore 6 e 7; entre HBP e CaP escore 6; entre CaP escore 6 e os grupos CaP escore 7 e 9 e entre CaP escore 7 e CaP 9. O potencial de reconhecimento da lectina permitiu identificar alterações de glicosilação associadas ao câncer de próstata e distinguir das amostras não cancerosas e entre os diferentes escores de CaP. Esses resultados sugerem a possibilidade de aplicação em estudos futuros envolvendo caracterização de glicosilação em câncer. / Prostate cancer (PCa) is a most frequently type of malignancy in global population and is also a major cause of cancer mortality. It usually occurs in older men and is not perceived in early stages. To detect the prostate cancer, this is of great importance the evaluation of serum prostate specific antigen (PSA), considered the prostate tumor marker. But, changes in serum PSA levels are also observed in benign prostate diseases, reducing the sensitivity and specificity of the test to obtain the diagnosis. A peculiarity of cancer that may be relevant in the diagnosis is the change in the pattern of glycosylation in glycoproteins secreted and cell surface. The identification of changes in the expression of glycans permits detection early of various types of cancer, including prostate cancer. Lectins are tools used to analyze such changes in diseases, through to the property to recognize carbohydrates with specificity. A great innovation in the field of studies with lectins is the development of smalls devices known as electrochemical biosensors based on lectins for analysis of the glycoproteins profile in physiopathological processes. These devices are typically produced using modified electrodes containing polymers, nanomaterials, where in the lectin may be immobilized and the interaction with carbohydrate quantified with high sensitivity in real time. This work presents a bioelectrochemical study of lectin of Cratylia mollis (CramoLL) to characterize the glycosylation pattern in sera from healthy individuals, with benign prostatic hyperplasia (BPH) and PCa, using electrochemical biosensor based on CramoLL immobilized on glassy carbon electrode modified with the polymer cationic poly-L-lysine (PLL) and carbon nanotubes (CNT). Electrochemical and optical analysis showed the formation of a PLL and CNT film on the electrode surface, where the CNT provided an increase in sensor area of 71.2%, and the anodic and cathodic current values, and increased stability of the surface due to the physical and chemical properties of these nanostructures. The optimal concentrations of PLL and NTC were investigated. CramoLL was successfully immobilized at a great concentration of 200 μg mL-1. The interaction between CramoLL and methyl-α-Dmannopyranose (MeαMan)/ fetuin was confirmed using voltammetry square wave technique, showing that the lectin retained its biological activity after immobilization. Calibration curves were plotted for different concentrations of the glycans with a linear range of 0.96 and 38.4 μg mL-1 for MeαMan (r = 0.982, p <0.001) and limit of detection (LOD) of 0.04 μg mL-1, and from 0.5 to 25 μg mL-1 for fetuin (r = 0.994, p <0.001) and LOD = 0.05 μg mL-1. The CramoLL-based biosensor was exposed to serum samples from healthy individuals (control), and patients with BPH and PCa with Gleason scores of 6, 7 and 9 to analyze the interaction between CramoLL and glycoproteins of sera from each group. The signals of current by square wave voltammetry show significants differents between the control group and the groups of BPH, PCa score 6 and 7; between BPH and PCa score 6; between PCa score 6 and groups PCa score 7 and 9 and between PCa score 7 ad PCa score 9. The potential of specific recognition of the lectin allowed to identify changes in glycosylation associated at prostate cancer and to distinguish of non-cancerous samples and between the differents scores of PCa. The results suggest the possibility of using in future studies involved characterization of glycosylation in cancer.

No description available.

L’objectif de cette thèse, dans le cadre de l'ANR TRICETOX (CESA, 2013-2017), était de développer des méthodes alternatives aux méthodes d’analyse chimiques classiques pour la détection spécifique des herbicides de la famille des β-tricétones. Ces nouveaux outils analytiques doiventt être faciles à utiliser, rapides, peu coûteux et devant répondre aux exigences imposées pour la détection de ces herbicides (valeur critique de 0,1 µg.L-1). Les β-tricétones ont pour cible spécifique l'enzyme p-HydroxyPhénylPyruvate Dioxygénase (HPPD), impliquée dans la biosynthèse des caroténoïdes, son inhibition entraîne un blanchiment des feuilles des plantes traitées. Deux stratégies ont été envisagées, basées sur l’inhibition de l’HPPD : un bio-essai colorimétrique à cellules entières utilisant un clone recombinant d'Escherichia coli exprimant l’HPPD d’Arabidopsis thaliana, et un biocapteur enzymatique à transduction électrochimique. Le principe du bio-essai repose sur la capacité du clone recombinant à produire un pigment brun à partir de la voie de catabolisme de la tyrosine. L’addition de β-tricétones entraîne une diminution de la pigmentation dans le milieu. Après optimisation des conditions opératoires, les LODs obtenues pour la mésotrione, la tembotrione, la sulcotrione et la leptospermone sont de 0,069, 0,051, 0,038 et 20 μM, respectivement. En format biocapteur, l'enzyme HPPD purifiée a été immobilisé sur la surface d’une électrode de graphite sérigraphiée. Le biocapteur à enzyme libre a permis l’obtention de limites de détection de 1,36-10 M, 1,25.10-11 M et 1,08.10-11 M pour la sulcotrione, la tembotrione et la mésotrione, respectivement. A ce jour, des échantillons réels ont été analysés sur le bio-essai et les résultats ont été validés par HPLC. / The goal of this thesis, in the frame of the ANR TRICETOX (CESA, 2013-2017), was to develop some alternative methods to conventional chromatographic methods for the monitoring of the β-triketone herbicides. These new analytical tools have to be easy to handle, fast, low-cost, and to respond to the requirements for the detection of these herbicides (critical value of 0.1 μg.L-1). The β-triketones specifically target the 4-hydroxyphenylpyruvate dioxygenase (HPPD) enzyme, involved in the carotenoids biosynthesis in plants ; its inhibition results in foliage bleaching of the treated plant. Two strategies have been considered, both based on the HPPD inhibition : a whole-cell colorimetric bioassay involving a recombinant E. coli expressing the HPPD from A. thaliana, and an electrochemical enzymatic biosensor. The principle of the bioassay is based on the ability of the recombinant E. coli clone to produce a soluble brown pigment from tyrosine catabolism. The addition of β-triketone induces the decrease of the pigment production in the medium. After optimization of the operational conditions, the LODs obtained for mesotrione, tembotrione, sulcotrione, and leptospermone were 0.069, 0.051, 0.038, and 20 μM, respectively. In the biosensor format, the purified HPPD enzyme was immobilized on the surface of a screen-printed graphite electrode. Using the free enzyme biosensor, LODs as low as 1.36-10 M, 1.25.10-11 M and 1.08.10-11 M were obtained for sulcotrione, mesotrione and tembotrione, respectively. Up to date, real samples have been analyzed using the bioassay and the results were validated by HPLC.

La phophomannose isomérase de type I (PMI), une métalloenzyme à zinc, et la phosphoglucose isomérase (PGI), catalysent l’isomérisation réversible du β-D-fructose-6-phosphate (F6P), respectivement en β-D-mannose-6-phosphate (M6P) et en α-D-glucose-6-phosphate (G6P). Ces deux enzymes sont des cibles thérapeutiques potentielles. La phosphoglucose isomérase humaine (hPGI), connu également sous le nom de facteur de motilité autocrine (AMF), stimule, en plus de son activité glycolytique intracellulaire, la migration des cellules in vitro et le développement de métastases in vivo. D'autre part, Candida albicans est la principale levure impliquée en pathologie humaine. Ces dernières années, un problème de résistance du germe aux antifongiques classiques est apparu. En conséquence, la recherche se dirige vers de nouvelles cibles thérapeutiques, dont la PMI de C. albicans (CaPMI) qui joue un rôle important dans la biosynthèse de structures mannosylées nécessaires à la survie du pathogène. Les réactions catalysées par ces deux enzymes mettent en jeu le même intermédiaire de haute énergie (IHE) de type 1,2-cis-ènediolate, sauf qu’il est coordiné au zinc dans le cas de la PMI. La surexpression ainsi que la purification de CaPMI et de hPGI ont été réalisées au laboratoire. Une petite chimiothèque a été créée à partir du 5-phospho-D-arabinono-1,4-lactone (5-PAL) en modulant la partie tête de l’IHE. Un groupe chélatant du zinc (zinc binding group, ZBG) a été introduit dans plusieurs composés dans le but d’inhiber sélectivement CaPMI. De plus, deux composés possédant en partie tête une fonction amine terminale ont été synthétisés pour inhiber spécifiquement la PGI humaine en ciblant un résidu glutamate du site actif de l'enzyme (Glu357). Toutes ces molécules ont d’abord été testées sur la PGI du muscle de lapin et la PMI de E. coli commerciales, et par la suite sur la CaPMI et la hPGI surexprimées. Une série de bons voire très bons inhibiteurs de hPGI, et donc potentiellement anti-métastatiques, a été découverte. Ces composés ne sont cependant pas inhibiteurs de la CaPMI. Deux structures tridimensionnelles à haute résolution de complexes enzyme-inhibiteur ont été obtenues. Au delà des aspects thérapeutiques, mécanistiques et structuraux, un biocapteur électrochimique à base d'un des inhibiteurs synthétisés a été réalisé pour la détection de hPGI qui est un biomarqueur validé de cancers métastatiques. Ce biocapteur a démontré une limite de détection de 43 fM dans du tampon phosphate (PBS). / Phosphoglucose isomerase (PGI) and type I phosphomannose isomerase (PMI), a zinc metalloenzyme, catalyze the reversible isomerization of β-D-fructose 6-phosphate (F6P) to α-D-glucose 6-phosphate (G6P) and β-D-mannose 6-phosphate (M6P), respectively. These two enzymes are potential therapeutic targets. Human PGI (hPGI) often called as AMF-PGI (autocrine motility factor-PGI), in addition to its intracellular glycolytic activity, stimulates cell migration in vitro and metastasis in vivo. Inhibition of its extracellular activity is obviously interesting in oncology. On the other hand, Candida albicans is the main yeast involved in human pathology. During recent years, resistance of this pathogenic fungus to conventional antifungal drugs appeared. Consequently, research is moving towards new therapeutic targets, including C. albicans PMI (CaPMI) that plays an important role in the biosynthesis of mannosylated structures required for pathogen survival. The reactions catalyzed by these two enzymes involve the same high energy intermediate (HEI) type 1,2-cis-enediolate, except that it is coordinated to the zinc active site in the case of PMI. Overexpression and purification of both CaPMI and hPGI were performed in our laboratory. A small chemical library was created from the synthon 5-phospho-D-arabinono-1,4-lactone (5-PAL) by modulating the head part of the HEI. A zinc binding group (ZBG) was introduced in several compounds in order to selectively inhibit the CaPMI enzyme. Moreover, two compounds with a terminal amine function were designed to selectively inhibit hPGI by targeting a glutamate residue of the enzyme (Glu357). All these molecules were first tested on rabbit muscle PGI and PMI from E. coli, and later on CaPMI and hPGI. None of these compounds are good inhibitors of CaPMI. However, a series of strong inhibitors of hPGI, and therefore potentially anti-metastatic drugs, was discovered. High-resolved 3D structures of the two enzymes complexed with inhibitors have been successfully obtained. Beyond the therapeutic, mechanistic and structural aspects, an electrochemical biosensor based on one of the synthesized inhibitors was carried out for the detection of hPGI, which is a validated biomarker of metastatic cancers. This biosensor demonstrated a detection limit of 43 fM in phosphate buffer (PBS).